Related Experiment Video
Updated: Jun 2, 2026
08:56
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Fibrosis in chronic viral hepatitis
Vincenza Calvaruso1, Antonio Craxì
1Sezione di Gastroenterologia ed Epatologia, Di.Bi.M.I.S., University of Palermo, Piazza delle Cliniche n.2, 90127 Palermo, Italy. vcalvaruso@libero.it
Best Practice & Research. Clinical Gastroenterology
|April 19, 2011
Summary
Antiviral therapies for chronic viral hepatitis significantly improve liver health. Treatments like entecavir and tenofovir for hepatitis B, and interferon for hepatitis C, reduce liver inflammation, fibrosis, and hepatocellular carcinoma risk.
Area of Science:
- Hepatology
- Virology
- Gastroenterology
Background:
- Chronic viral hepatitis, including hepatitis B and C, remains a significant global health concern.
- Fibrosis progression and hepatocellular carcinoma (HCC) are major complications of chronic viral hepatitis.
- Antiviral therapies aim to suppress viral replication and mitigate liver damage.
Purpose of the Study:
- To evaluate the impact of antiviral treatments on fibrosis progression in chronic viral hepatitis.
- To assess the effectiveness of nucleoside/nucleotide analogs and interferon therapy.
- To understand the role of novel direct-acting antiviral agents.
Main Methods:
- Review of studies evaluating antiviral treatments for chronic viral hepatitis.
- Analysis of histological improvements and virologic response rates.
- Assessment of outcomes such as hepatic inflammation, fibrosis, liver decompensation, and HCC occurrence.
Main Results:
- Nucleoside and nucleotide analogs (entecavir, tenofovir) for chronic hepatitis B demonstrated histological improvement in 72% of patients.
- Sustained virologic response to interferon therapy in chronic hepatitis C correlated with fibrosis regression and reduced liver decompensation and HCC.
- Viral suppression is a key therapeutic goal, leading to improved liver outcomes.
Conclusions:
- Antiviral treatments are effective in improving liver inflammation and fibrosis in chronic viral hepatitis.
- Achieving sustained virologic response is crucial for long-term outcomes in hepatitis C.
- Future research will focus on the impact of new direct-acting antiviral agents on liver disease progression.
More Related Videos
Related Concept Videos
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...